Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?
Background: ACE2, a component of the non-classic renin-angiotensin system (RAS), acts as a functional receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) spike protein, which enables the entry of the virus into the host cells. Non-classical ACE2 is one of two types of ACE2 that...
Main Authors: | Shakhi Shylesh C.M, Arya V S, Kanthlal S. K., Uma Devi P. |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-01-01
|
Series: | Clinical and Experimental Hypertension |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10641963.2021.1963070 |
Similar Items
-
The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic
by: Marco Prato, et al.
Published: (2024-03-01) -
The Effect of Local Renin Angiotensin System in the Common Types of Cancer
by: Moudhi Almutlaq, et al.
Published: (2021-09-01) -
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
by: Jose L. Labandeira-Garcia, et al.
Published: (2022-02-01) -
Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity
by: Wanyu Wang, et al.
Published: (2018-07-01) -
Impact of the Renin–Angiotensin System on the Endothelium in Vascular Dementia: Unresolved Issues and Future Perspectives
by: Fatima Y. Noureddine, et al.
Published: (2020-06-01)